Stockreport

Galecto to Participate in Oppenheimer’s 33rd Annual Healthcare Conference

Galecto, Inc.  (GLTO) 
PDF BOSTON, March 02, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and a world leader in galectin biology focused on the d [Read more]